10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001410578-25-001164`
Period End Date	20250331
Filing Date	20250509
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	enzn-20250331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 96 Income Statement 52 Cash Flow Statement 48 Stockholders Equity 24

Balance Sheet 96 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.97M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$293.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$293.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$555.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$555.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$45.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$45.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.15M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$17.00K	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$17.00K	USD	Point-in-time
Total assets	`Assets`	$47.17M	USD	Point-in-time
Total assets	`Assets`	$47.17M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets	`Assets`	$45.52M	USD	Point-in-time
Total assets	`Assets`	$45.52M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$72.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$72.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$223.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$223.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Dividends payable on Series C preferred stock	`DividendsPayableCurrent`	$1.27M	USD	Point-in-time
Dividends payable on Series C preferred stock	`DividendsPayableCurrent`	$1.27M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$554.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$554.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at March 31, 2025 and December 31, 2024	`CommonStockValue`	$742.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$71.63M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$71.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.42M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.95M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.17M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.17M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$45.52M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$45.52M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.00M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.00M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$326.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$326.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$326.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$326.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.00M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.00M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.00M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-326.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-326.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$497.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$497.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$647.00K	USD	1 Quarter
Interest and dividend income	`OtherInterestAndDividendIncome`	$647.00K	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-505.00K	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-505.00K	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$321.00K	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$321.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$19.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$19.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-211.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-211.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.05M	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.05M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter
Weighted average number of common shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.22M	shares	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$17.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$17.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$68.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$68.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$111.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$111.00K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$251.00K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$251.00K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-618.00K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-618.00K	USD	1 Quarter
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	1 Quarter
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	1 Quarter
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	1 Quarter
Preferred stock dividend payments	`PaymentsOfDividendsCommonStock`	$1.27M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.27M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.02M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.02M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.89M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.89M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.97M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.97M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.99M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.99M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.97M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.97M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.01M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.86M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.99M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.99M	USD	Point-in-time
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter
Accretion of dividend for Series C Preferred Stock	`AccretionOfDividendForSeriesCPreferredStock`	$531.00K	USD	1 Quarter

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$1.95M	USD	Point-in-time
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$320.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-524.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Preferred stock dividend accretion	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$531.00K	USD	1 Quarter
Balance at the ending	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.50M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.29M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$3.01M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$1.95M	USD	Point-in-time
Balance at the ending	`StockholdersEquity`	$1.95M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.